Animal Model Market Size, Share, Growth Report 2032

Global Animal Model Market Size: Industry Prospective

The global animal model market size was worth around $1.4 billion in 2021 and is predicted to grow to around revenue of $2.5 billion by 2028 at a CAGR rate of 6% over the forecast period. In this report, we will cover the full overview, growth drivers, opportunities, and obstacles of the animal model market from 2022 to 2028.

Request Free Sample

Global Animal Model Market: Overview

The animal model refers to the animals on which biological and pathological experiments are done. They become the testing materials before they are tried in the human body. There are some protocols and guidelines to be followed while leveraging animal models for studies.

Both humans and animals have similar biological and physiological structures. Though animals have a shorter lifespan, they match the genotype resemblance so much that the results are parallel. Even the organic framework of those animals aligns with humans. Scientists and researchers find the cure for any disease by testing those medicinal components on animals until their trial succeeds. They also come up with new products based on the outcome they get out of those experiments.

These drugs that are tested on the animals are also validated for the efficacy of the recovery. The safety quotient of the medications is also determined through these animal model tests. They find applications in all fields like research & development, production, quality control, and academics.

Request Free Sample

Animal Model Market- Covid-19 Impact:

The animal model market has had significant growth during the pandemic times. The production and testing of vaccines took a lot of prominence during that time and animal model testing became more popular. The researchers and drug developers detected positive and negative results using animal model testing to develop the vaccinations. The efficacy rate was also determined with the help of this method. The adverse impact of vaccines was also discovered through animal model experimentation. Hence the therapeutic treatment for SARS-COV-2 was devised through the leverage of animal model testing thereby amplifying its market rate to a large extent.

Global Animal Model Market Size: Growth Drivers

Growth in drug discovery and innovations in the pharmaceutical sectors drives the market growth

Drug discovery and the emergence of vaccinations have grown exponentially in recent times due to the rise of multiple diseases and chronic illnesses. This has induced scientists and researchers to come up with new treatment methods and medications at a faster pace. Hence animal model testing has increased rapidly due to these factors thereby amplifying the global market rate substantially.

Researchers across the world are focusing on genetically modified models to perfect the outcomes of any testing. The metabolic ways, life processes, and organic structures of the testing animals should match with that of humans to achieve accuracy. This factor contributes to revenue growth exclusively.

Cancer disease has become more prominent in many regions and medications for treatment require strenuous testing experiments which can be achieved through animal models. Research grants and government initiatives to support such a mission are also boosting the global animal model market growth across all regions. The prevalence of the geriatric population and the prominence of chronic illness amongst them also supports the market exquisitely.

Animal models are being leveraged also to understand the intensity of diseases and the symptoms associated with them. The efficacy of vaccinations and prevention procedures are also deducted with the help of animal models to a large extent. These factors offer a huge surge in the development of healthcare sectors thereby nudging the market growth.

Animal Model Market: Restraints

The cost of animal model studies and the strict regulations from the authorities restrain the market growth

The expensive method of study along with all the regulations implemented by the higher officials regarding animal model testing impedes market growth. There are also vivid ethical concerns from the animal protection organizations to safeguard the animals which hampers the expansion of the market. The harmful effects of these experiments on the animals disrupt their normal life rendering them physically and mentally impaired. They also lead to lethal impact on the animals which gives a lot of concern thereby restricting the market growth.

Animal Model Market: Opportunities

Growth opportunities in the healthcare sectors and methods to improve the precision of test results provides opportunities for market expansion

In recent years, the demand for animal models in the research and development of new drugs and therapies has driven the market for animal models to expand consistently. Here are some market opportunities for animal models:

• The growth opportunities in the healthcare sector and innovative techniques to achieve precision in the testing results provides lucrative opportunities for the global animal model market. The government support rendered with the development of standard protocols allied with animal model testing to cure new diseases offers exceptional opportunities for market expansion.
• Increasing demand for personalized medicine: The expanding field of personalized medicine aims to tailor medical treatment to individual patients. Animal models can play a crucial role in the development of personalized medicine by enhancing our understanding of how different patients may react to treatments.
• Advancements in gene editing technologies: CRISPR/Cas9 and other gene editing technologies have facilitated the creation of animal models that are genetically modified to mimic human diseases. This has increased the demand for animal models that have been genetically modified for research and development.
• Rising demand for preclinical studies: For the development of new drugs and therapies, preclinical research is essential. The market for animal models is anticipated to expand as pharmaceutical and biotechnology companies continue to invest in preclinical research.

Animal Model Market: Challenges

The high cost associated with the equipment and studies based on animal models poses a challenge to the market growth

The expensive animal model experiments and study procedures along with the facilities required for that come across as a challenge for revenue growth. The demand and leverage of these tests are restricted due to this factor which also impedes market expansion.

Harmful effects on the animals due to these tests challenge market expansion

Many new innovative programs and techniques for animal model testing have been on the rise. However, the impact it causes on the animals being tested results in their death or disruption of their regular lifestyle. This brings a lot of ethical concerns which also challenge the market expansion to some extent.

Animal Model Market: Segmentation

The global animal model market is fragmented into animal type, technology, application, end-user, and region. Animal types consist of pigs, cats, and mice. The applications are classified as research, development, production, and quality control. The end-users include research institutes, educational institutes, pharmaceutical institutes, and contract research organizations.

Recent Developments:

• In April 2021, Horizon Discovery Group created and developed IgM antibodies and obtained a license for the commercial agreement of animal model testing.
• In October 2020, Mammoth Bioscience secured a new license for the generation of CHO cells using mice testing procedures.

Report Scope:

Animal Model Market: Regional Landscape:

North America to lead the global market during the upcoming period

The region that is touted to be a significant contributor to the global animal model market is North America. This is favored by the increasing support and investments made by the government for the improvisation of the healthcare sector. There are so many health reform policies nudging the growth of research and development on treatment methods based on animal model studies. Asia-Pacific region is next in line as a significant contributor due to the free hand given by the government for animal model testing. There is no restriction or strict regulations to curtail this procedure in the region. The rise in the geriatric population and their chronic illnesses also impacts the global market positively.

Global Animal Model Market: Competitive Landscape:

The key players in the global animal model market are Horizon Discovery Group, Charles River Laborotories International, Inc., Transposagen Biopharmaceuticals, Inc., Trans Genic Inc, Envigo CRS SA, Eurofins Scientific SE, Crown Bioscience, INC., The Jackson Laboratory, and Genoway SA.

The global animal model market is segmented as follows:

By Animal Type

• Pigs
• Cats
• Mice

By Application

• Research
• Development
• Production
• Quality Control

By End-Users

• Research Institutes
• Educational Institutes
• Pharmaceutical Organizations
• Contract Research Organizations

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa